Brief: Novan Completes Enrollment In B-SIMPLE4 Pivotal Phase 3 Study Of SB206 For Treatment Of Molluscum
01/02/2021 13:15
Feb 1 (Reuters) - Novan Inc NOVN.O :
* NOVAN COMPLETES ENROLLMENT IN B-SIMPLE4 PIVOTAL PHASE 3
STUDY OF
SB206 FOR TREATMENT OF MOLLUSCUM
* NOVAN INC - TOPLINE DATA ON TRACK FOR TARGETED READOUT
BEFORE
END OF Q2 2021
Source text for Eikon: ID:nGNX8vMt6P
Further company coverage: NOVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NVN Liquidation
See all newsBrief: Nvn Liquidation Says On April 30, Debtors Filed Notice Of Effective Date With Bankruptcy Court
Brief: Novan Received Notice From Nasdaq Notifying Co's Securities Will Be Delisted From Nasdaq
Brief: Novan Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. STOCKS ON THE MOVE-Lands' End, Energy sector
U.S. STOCKS ON THE MOVE-Biogen, NetApp, LyondellBasell